image
ICU Medical, Inc. ICUI
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
Watchlist
$ 142.25
2.1 %
$ 3.49 B
Market Cap
-29.45
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ICUI stock under the worst case scenario is HIDDEN Compared to the current market price of 142 USD, ICU Medical, Inc. is HIDDEN

ICUI Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ICUI stock under the base case scenario is HIDDEN Compared to the current market price of 142 USD, ICU Medical, Inc. is HIDDEN

ICUI Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ICUI stock under the best case scenario is HIDDEN Compared to the current market price of 142 USD, ICU Medical, Inc. is HIDDEN

ICUI Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart ICUI

image
1M --%
6M -24%
1Y 45%
3Y -57.0%
5Y -49%
All
$190.0$190.0$180.0$180.0$170.0$170.0$160.0$160.0$150.0$150.0$140.0$140.0$130.0$130.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
2.38 B REVENUE
5.44%
Growth Rates
1Year 5.44%
3Years 21.86%
5Years 13.47%
7Years 9.13%
10Years 22.65%
43 M OPERATING INCOME
88.23%
Growth Rates
1Year 88.23%
3Years -6.39%
5Years -7.43%
7Years 25.30%
10Years 0.96%
-118 M NET INCOME
-296.86%
Growth Rates
1Year -296.86%
3Years -28.89%
5Years -16.70%
7Years -15.33%
10Years -18.52%
204 M OPERATING CASH FLOW
22.76%
Growth Rates
1Year 22.76%
3Years -8.64%
5Years 14.89%
7Years 4.06%
10Years 12.90%
-89 M INVESTING CASH FLOW
-1.15%
Growth Rates
1Year -1.15%
3Years 0.64%
5Years 11.82%
7Years 14.52%
10Years -15.13%
-55.8 M FINANCING CASH FLOW
-55.09%
Growth Rates
1Year -55.09%
3Years -49.00%
5Years -38.61%
7Years -3.34%
10Years -14.53%
630 M REVENUE
6.90%
Growth Rates
1Year 5.44%
3Years 21.86%
5Years 13.47%
7Years 9.13%
10Years 22.65%
37.7 M OPERATING INCOME
357.64%
Growth Rates
1Year 88.23%
3Years -6.39%
5Years -7.43%
7Years 25.30%
10Years 0.96%
-23.8 M NET INCOME
27.76%
Growth Rates
1Year -296.86%
3Years -28.89%
5Years -16.70%
7Years -15.33%
10Years -18.52%
40.2 M OPERATING CASH FLOW
11.34%
Growth Rates
1Year 22.76%
3Years -8.64%
5Years 14.89%
7Years 4.06%
10Years 12.90%
-26.5 M INVESTING CASH FLOW
-16.12%
Growth Rates
1Year -1.15%
3Years 0.64%
5Years 11.82%
7Years 14.52%
10Years -15.13%
-8.19 M FINANCING CASH FLOW
21.09%
Growth Rates
1Year -55.09%
3Years -49.00%
5Years -38.61%
7Years -3.34%
10Years -14.53%
Balance Sheet ICU Medical, Inc.
image
Current Assets 1.44 B
Cash & Short-Term Investments 309 M
Receivables 203 M
Other Current Assets 931 M
Non-Current Assets 2.76 B
Long-Term Investments 0
PP&E 496 M
Other Non-Current Assets 2.27 B
7.34 %4.82 %22.14 %11.80 %53.90 %Total Assets$4.2b
Current Liabilities 556 M
Accounts Payable 148 M
Short-Term Debt 51 M
Other Current Liabilities 357 M
Non-Current Liabilities 1.68 B
Long-Term Debt 1.53 B
Other Non-Current Liabilities 151 M
6.61 %15.95 %68.43 %6.73 %Total Liabilities$2.2b
EFFICIENCY
Earnings Waterfall ICU Medical, Inc.
image
Revenue 2.38 B
Cost Of Revenue 1.56 B
Gross Profit 825 M
Operating Expenses 782 M
Operating Income 43 M
Other Expenses 161 M
Net Income -118 M
3b3b2b2b2b2b1b1b500m500m00(500m)(500m)2b(2b)825m(782m)43m(161m)(118m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
34.62% GROSS MARGIN
34.62%
Averages
1Year 34.62%
3Years 32.66%
5Years 34.33%
7Years 35.66%
10Years 38.86%
1.80% OPERATING MARGIN
1.80%
Averages
1Year 1.80%
3Years 0.81%
5Years 1.94%
7Years 2.32%
10Years 5.70%
-4.94% NET MARGIN
-4.94%
Averages
1Year -4.94%
3Years -3.17%
5Years 1.03%
7Years 2.17%
10Years 5.03%
-5.99% ROE
-5.99%
Averages
1Year -5.99%
3Years -3.65%
5Years 0.25%
7Years 1.55%
10Years 3.39%
-2.80% ROA
-2.80%
Averages
1Year -2.80%
3Years -1.71%
5Years 1.06%
7Years 1.87%
10Years 3.38%
2.07% ROIC
2.07%
Averages
1Year 2.07%
3Years 0.72%
5Years 1.42%
7Years 1.86%
10Years 2.83%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis ICU Medical, Inc.
image
200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -118 M
Depreciation & Amortization 220 M
Capital Expenditures -79.4 M
Stock-Based Compensation 46.9 M
Change in Working Capital 0
Others 55.3 M
Free Cash Flow 125 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets ICU Medical, Inc.
image
Wall Street analysts predict an average 1-year price target for ICUI of $153 , with forecasts ranging from a low of $97 to a high of $198 .
ICUI Lowest Price Target Wall Street Target
97 USD -31.81%
ICUI Average Price Target Wall Street Target
153 USD 7.73%
ICUI Highest Price Target Wall Street Target
198 USD 39.19%
Price
Max Price Target
Min Price Target
Average Price Target
2002001801801601601401401201201001008080May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership ICU Medical, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
6.52 M USD 4
6-9 MONTHS
6.68 M USD 3
9-12 MONTHS
1.55 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. SAN CLEMENTE, Calif. prnewswire.com - 6 days ago
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference SAN CLEMENTE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 24th Annual Needham Virtual Healthcare Conference being held April 7-10, 2025. ICU Medical's presentation will be on Monday, April 7, 2025 at 8:00 a.m. PT (11:00 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, April 7, 2025. globenewswire.com - 2 weeks ago
ICU Medical to Participate at the KeyBanc Healthcare Forum SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the KeyBanc Healthcare Forum being held virtually, March 18-19, 2025. ICU Medical's fireside chat will be on Wednesday, March 19, 2025 at 8:15 a.m. PT (11:15 a.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 19, 2025. globenewswire.com - 1 month ago
ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call Transcript ICU Medical, Inc. (NASDAQ:ICUI ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants John Mills - ICR, IR Vivek Jain - Chairman and CEO Brian Bonnell - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Brett Fishbin - KeyBanc Capital Markets Charlie Strauzer - CJS Securities Michael Toomey - Jefferies Joseph Conway - Needham Operator Good day. And welcome to the ICU Medical, Inc. Fourth Quarter 2024 Earnings Conference Call. seekingalpha.com - 1 month ago
ICU Medical (ICUI) Q4 Earnings and Revenues Top Estimates ICU Medical (ICUI) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.57 per share a year ago. zacks.com - 1 month ago
ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance SAN CLEMENTE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2024. globenewswire.com - 1 month ago
ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2024 earnings release and conference call. globenewswire.com - 1 month ago
ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 46th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-5, 2025. ICU Medical's presentation will be on Monday, March 3, 2025 at 5:40 a.m. PT (8:40 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, March 3, 2025. globenewswire.com - 1 month ago
New Strong Buy Stocks for January 14th BWAY, EE, MATW, BRBR and FMAO have been added to the Zacks Rank #1 (Strong Buy) List on January 14, 2025. zacks.com - 2 months ago
ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference SAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ICU Medical's presentation will be on Wednesday, January 15, 2025 at 10:30 a.m. PT (1:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 15, 2025 and Thursday, January 16, 2025. globenewswire.com - 3 months ago
ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript ICU Medical Inc. (NASDAQ:ICUI ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - Chief Executive Officer and Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Brett Fishbin - KeyBanc Eric Fleming - Raymond James Larry Solow - CJS Securities Kristen Stewart - CL King Mike Matson - Needham and Company Michael Toomey - Jefferies Operator Good day, everyone, and welcome to today's ICU Medical Inc.'s Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 5 months ago
ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates ICU Medical (ICUI) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.57 per share a year ago. zacks.com - 5 months ago
8. Profile Summary

ICU Medical, Inc. ICUI

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 3.49 B
Dividend Yield 0.00%
Description ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Contact 951 Calle Amanecer, San Clemente, CA, 92673 https://www.icumed.com
IPO Date March 31, 1992
Employees 15000
Officers Mr. Christian B. Voigtlander Chief Operating Officer Ms. Virginia Ruth Sanzone Corporate Vice President, General Counsel, Secretary & Compliance Officer Mr. Brian Michael Bonnell Chief Financial Officer & Treasurer Mr. Vivek Jain Chief Executive Officer & Chairman of the Board